Skip to main content

Table 2 Overall and disease-free survival based on the NMU expression of peri- and intra-tumor tissue

From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma

GroupcaseOverall survivalDisease-free survival
1 year (%)3 years (%)5 years (%)1 year (%)3 years (%)5 years (%)
All22869.746.138.943.430.326.2
Peri-tumor
 Low13372.254.946.646.636.132.2
 High9566.333.728.438.922.117.4
Intra-tumor
 Low13769.348.941.648.231.429.3
 High9170.341.834.842.228.922.0